DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Munster PN, Buzdar A, Dhingra K, Enas N, Ni L, Major M. et al.
Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCL, in metastatic breast cancer.
J Clin Oncol 2001; 19: 2002-9
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.